194 related articles for article (PubMed ID: 35333703)
21. Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia.
Ronchetti D; Tuana G; Rinaldi A; Agnelli L; Cutrona G; Mosca L; Fabris S; Matis S; Colombo M; Gentile M; Recchia AG; Kwee I; Bertoni F; Morabito F; Ferrarini M; Neri A
Genes Chromosomes Cancer; 2014 Mar; 53(3):264-73. PubMed ID: 24347044
[TBL] [Abstract][Full Text] [Related]
22.
Maity PC; Bilal M; Koning MT; Young M; van Bergen CAM; Renna V; Nicolò A; Datta M; Gentner-Göbel E; Barendse RS; Somers SF; de Groen RAL; Vermaat JSP; Steinbrecher D; Schneider C; Tausch E; Bittolo T; Bomben R; Mazzarello AN; Del Poeta G; Kroes WGM; van Wezel JT; Imkeller K; Busse CE; Degano M; Bakchoul T; Schulz AR; Mei H; Ghia P; Kotta K; Stamatopoulos K; Wardemann H; Zucchetto A; Chiorazzi N; Gattei V; Stilgenbauer S; Veelken H; Jumaa H
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4320-4327. PubMed ID: 32047037
[TBL] [Abstract][Full Text] [Related]
23. IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus.
Drennan S; D'Avola A; Gao Y; Weigel C; Chrysostomou E; Steele AJ; Zenz T; Plass C; Johnson PW; Williams AP; Packham G; Stevenson FK; Oakes CC; Forconi F
Leukemia; 2017 Aug; 31(8):1686-1694. PubMed ID: 27890932
[TBL] [Abstract][Full Text] [Related]
24. 98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia.
Shi K; Sun Q; Qiao C; Zhu H; Wang L; Wu J; Wang L; Fu J; Young KH; Fan L; Xia Y; Xu W; Li J
Cancer Med; 2020 Feb; 9(3):999-1007. PubMed ID: 31849198
[TBL] [Abstract][Full Text] [Related]
25. Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups.
MacIntyre DA; Jiménez B; Lewintre EJ; Martín CR; Schäfer H; Ballesteros CG; Mayans JR; Spraul M; García-Conde J; Pineda-Lucena A
Leukemia; 2010 Apr; 24(4):788-97. PubMed ID: 20090781
[TBL] [Abstract][Full Text] [Related]
26. Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemia.
Henriques A; Rodríguez-Caballero A; Nieto WG; Langerak AW; Criado I; Lécrevisse Q; González M; Pais ML; Paiva A; Almeida J; Orfao A
PLoS One; 2013; 8(7):e67751. PubMed ID: 23844084
[TBL] [Abstract][Full Text] [Related]
27. Normal serum protein electrophoresis and mutated IGHV genes detect very slowly evolving chronic lymphocytic leukemia patients.
Chauzeix J; Laforêt MP; Deveza M; Crowther L; Marcellaud E; Derouault P; Lia AS; Boyer F; Bargues N; Olombel G; Jaccard A; Feuillard J; Gachard N; Rizzo D
Cancer Med; 2018 Jun; 7(6):2621-2628. PubMed ID: 29745034
[TBL] [Abstract][Full Text] [Related]
28. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
[TBL] [Abstract][Full Text] [Related]
29. Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B cells.
Ghiotto F; Marcatili P; Tenca C; Calevo MG; Yan XJ; Albesiano E; Bagnara D; Colombo M; Cutrona G; Chu CC; Morabito F; Bruno S; Ferrarini M; Tramontano A; Fais F; Chiorazzi N
Mol Med; 2011; 17(11-12):1188-95. PubMed ID: 21785810
[TBL] [Abstract][Full Text] [Related]
30. STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage.
Rozovski U; Harris DM; Li P; Liu Z; Jain P; Ferrajoli A; Burger JA; Bose P; Thompson PA; Jain N; Wierda WG; Uziel O; Keating MJ; Estrov Z
J Immunol; 2019 Dec; 203(11):3078-3085. PubMed ID: 31645416
[TBL] [Abstract][Full Text] [Related]
31. Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia.
Hojjat-Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Mellstedt H; Shokri F; Rabbani H
Cancer Sci; 2009 Dec; 100(12):2346-53. PubMed ID: 19824994
[TBL] [Abstract][Full Text] [Related]
32. ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia.
Martinelli S; Kanduri M; Maffei R; Fiorcari S; Bulgarelli J; Marasca R; Rosenquist R
Epigenetics; 2013 Jul; 8(7):720-9. PubMed ID: 23803577
[TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia.
Stanganelli C; Travella A; Bezares R; Slavutsky I
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):447-457.e2. PubMed ID: 23665144
[TBL] [Abstract][Full Text] [Related]
34. Expression of
Plešingerová H; Janovská P; Mishra A; Smyčková L; Poppová L; Libra A; Plevová K; Ovesná P; Radová L; Doubek M; Pavlová Š; Pospíšilová Š; Bryja V
Haematologica; 2018 Feb; 103(2):313-324. PubMed ID: 29122990
[TBL] [Abstract][Full Text] [Related]
35. Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia.
Visco C; Moretta F; Falisi E; Facco M; Maura F; Novella E; Nichele I; Finotto S; Giaretta I; Ave E; Perbellini O; Guercini N; Scupoli MT; Trentin L; Trimarco V; Neri A; Semenzato G; Rodeghiero F; Pizzolo G; Ambrosetti A
Am J Hematol; 2013 Apr; 88(4):277-82. PubMed ID: 23450508
[TBL] [Abstract][Full Text] [Related]
36. Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments.
Visentin A; Facco M; Gurrieri C; Pagnin E; Martini V; Imbergamo S; Frezzato F; Trimarco V; Severin F; Raggi F; Scomazzon E; Pravato S; Piazza F; Semenzato G; Trentin L
Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):678-685.e4. PubMed ID: 31371221
[TBL] [Abstract][Full Text] [Related]
37. Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia.
Stamatopoulos B; Timbs A; Bruce D; Smith T; Clifford R; Robbe P; Burns A; Vavoulis DV; Lopez L; Antoniou P; Mason J; Dreau H; Schuh A
Leukemia; 2017 Apr; 31(4):837-845. PubMed ID: 27795555
[TBL] [Abstract][Full Text] [Related]
38. Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism.
Hasan MK; Ghia EM; Rassenti LZ; Widhopf GF; Kipps TJ
Leukemia; 2021 Jun; 35(6):1621-1630. PubMed ID: 33097837
[TBL] [Abstract][Full Text] [Related]
39. Network analysis reveals a major role for 14q32 cluster miRNAs in determining transcriptional differences between IGHV-mutated and unmutated CLL.
Bryant D; Smith L; Rogers-Broadway KR; Karydis L; Woo J; Blunt MD; Forconi F; Stevenson FK; Goodnow C; Russell A; Humburg P; Packham G; Steele AJ; Strefford JC
Leukemia; 2023 Jul; 37(7):1454-1463. PubMed ID: 37169950
[TBL] [Abstract][Full Text] [Related]
40. Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma.
Balakrishna J; Basumallik N; Matulonis R; Scott D; Salem D; Jasper G; Wiestner A; Stetler-Stevenson M; Marti G; Sun C; Yuan CM
Leuk Lymphoma; 2021 Aug; 62(8):1828-1839. PubMed ID: 33734005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]